Holen Sie sich die Stockscreener-App
102.90
0.05%
-0.05
Handel nachbörslich:
103.00
0.10
+0.10%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$102.95
Offen:
$102.99
24-Stunden-Volumen:
6.62M
Relative Volume:
0.92
Marktkapitalisierung:
$131.92B
Einnahmen:
$34.76B
Nettoeinkommen (Verlust:
$4.79B
KGV:
27.80
EPS:
3.7017
Netto-Cashflow:
$5.21B
1W Leistung:
-0.06%
1M Leistung:
+2.58%
6M Leistung:
+15.15%
1J Leistung:
+13.30%
1-Tages-Spanne:
$101.89
$103.75
1-Wochen-Bereich:
$101.19
$105.50
52-Wochen-Spanne:
$79.55
$106.33
Medtronic Plc Stock (MDT) Company Profile
Firmenname
Medtronic Plc
Sektor
Branche
Telefon
01135314381700
Adresse
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
102.90 | 131.98B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
ABT
Abbott Laboratories
|
110.83 | 189.68B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
358.29 | 138.60B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
BSX
Boston Scientific Corp
|
76.27 | 115.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.71 | 45.32B | 5.88B | 1.34B | 799.60M | 2.3489 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-03 | Fortgesetzt | Citigroup | Buy |
| 2026-01-30 | Fortgesetzt | Wells Fargo | Overweight |
| 2026-01-06 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2025-11-19 | Hochstufung | Goldman | Sell → Neutral |
| 2025-06-30 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-10-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Bestätigt | Oppenheimer | Perform |
| 2024-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2024-08-14 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Herabstufung | UBS | Buy → Sell |
| 2023-01-09 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-11-23 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-08-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-06-01 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-06-10 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-12-15 | Hochstufung | Goldman | Sell → Neutral |
| 2020-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Hochstufung | Stifel | Hold → Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-05-14 | Herabstufung | DZ Bank | Buy → Hold |
| 2020-03-30 | Herabstufung | Needham | Strong Buy → Buy |
| 2020-03-25 | Hochstufung | DZ Bank | Hold → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Sell |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-02 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-06-05 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Bestätigt | Needham | Strong Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-12-19 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-27 | Bestätigt | Argus | Buy |
Alle ansehen
Medtronic Plc Aktie (MDT) Neueste Nachrichten
Medtronic Hit with $382M Fine for Monopolizing Device Market - Medical Device and Diagnostic industry
University of Galway opens medtech prototype hub under Medtronic partnership - Medical Device Network
Medtronic Hernia Mesh Patent Suit Ends as Hexagon Drops Case - Bloomberg Law News
Medtronic PLC $MDT Shares Acquired by Willis Investment Counsel - MarketBeat
Aurdan Capital Management LLC Sells 11,655 Shares of Medtronic PLC $MDT - MarketBeat
Guinness Atkinson Asset Management Inc Buys Shares of 77,667 Medtronic PLC $MDT - MarketBeat
Guinness Asset Management LTD Buys New Shares in Medtronic PLC $MDT - MarketBeat
Orthopedic Implants Market Size to Reach USD 33.20 Billion by 2033, Driven by Rising Musculoskeletal Disorders and Surgical Innovation – SNS Insider - GlobeNewswire Inc.
J.W. Cole Advisors Inc. Purchases 21,099 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic Stock Under Pressure: Value Trap or Quiet Turnaround Story? - AD HOC NEWS
Medtronic reportedly must pay Applied Medical $382M over antitrust suit - MassDevice
Medtronic owes $382 million to medical device rival in antitrust lawsuit, US jury says - MSN
Us jury reaches $382 million verdict against Medtronic in antitrust lawsuitattorney for plaintiff Applied Medical Resources - marketscreener.com
Medtronic Hit With $382M Antitrust Verdict Over Bundling - Law360
UBS makes a modest target increase on Medtronic (MDT), keeps neutral rating - MSN
UBS Makes a Modest Target Increase on Medtronic (MDT), Keeps Neutral Rating - Insider Monkey
Medtronic: A Healthier Diagnosis (NYSE:MDT) - Seeking Alpha
Medtronic wins expanded FDA label for 780G insulin pump - MedTech Dive
Medtronic PLC $MDT Stock Holdings Lowered by Cullen Capital Management LLC - MarketBeat
Bessemer Group Inc. Raises Stake in Medtronic PLC $MDT - MarketBeat
Medtronic Owes $381M For Antitrust 'War Games,' Jury Told - Law360
Medtronic Expands Heart And Diabetes Tools As Valuation Nears Analyst Views - Yahoo Finance UK
Medtronic Structural Heart President Nina Goodheart to retire - MassDevice
Medtronic plc’s Quiet Power Play: How a Medtech Giant Is Re?architecting the Future of Chronic Car - AD HOC NEWS
Medtronic set to acquire CathWorks for $585m - Medical Device Network
Envestnet Asset Management Inc. Raises Stock Position in Medtronic PLC $MDT - MarketBeat
Equity Investment Corp Grows Stock Holdings in Medtronic PLC $MDT - MarketBeat
Are Wall Street analysts predicting Medtronic stock will climb or sink? - MSN
Medtronic to acquire CathWorks - Medical Buyer
Medtronic's Bundling Isn't Anticompetitive, Prof Tells Jury - Law360
Leerink Maintains Outperform on MDT Medtronic plc Feb 2026 - Meyka
Medtronic to Acquire CathWorks - Diagnostic and Interventional Cardiology
Medtronic to acquire Cathworks for $585M - BioWorld MedTech
Medtronic Expands Cath Market Reach with CathWorks Deal - Medical Device and Diagnostic industry
Medtronic Bets On AI Heart Care With $585 Million Deal For Partner CathWorks - Benzinga
Medtronic to acquire CathWorks for up to $585M - MedTech Dive
Medtronic plc agreed to acquire CathWorks Ltd. in a transaction valued at $585 million. - marketscreener.com
Medtronic expands cath lab portfolio with CathWorks acquisition - MassDevice
Medtronic (MDT) to Acquire CathWorks for Up to $585M - GuruFocus
Medtronic (MDT) Moves to Acquire CathWorks for $585 Million - GuruFocus
Medtronic advances its innovation strategy with intent to acquire Cathworks - marketscreener.com
Medtronic Strengthens Cardiovascular Portfolio With $585 Million CathWorks Deal - Medical Product Outsourcing
Medical device maker Medtronic plans to buy CathWorks in up to $585 million deal - marketscreener.com
Medical device maker Medtronic to buy CathWorks in up to $585 million deal - Reuters
Medtronic advances its innovation strategy with intent to acquire CathWorks - Investing News Network
Medtronic to Acquire CathWorks in Deal Valued Up to $585 Million - marketscreener.com
Medtronic to acquire CathWorks for up to $585 million By Investing.com - Investing.com India
Medtronic to expand cath lab portfolio with CathWorks acquisition - MassDevice
Medtronic to buy Israeli diagnostics co CathWorksGlobes - Globes - Israel Business News
Medtronic to acquire CathWorks for up to $585 million - Investing.com
Medtronic to exercise option to buy CathWorks for up to $585M (MDT:NYSE) - Seeking Alpha
Finanzdaten der Medtronic Plc-Aktie (MDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.14%
1.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):